Claire Pomeroy, MD

Claire Pomeroy is president and CEO of the Albert and Mary Lasker Foundation which is dedicated to improving health by accelerating support for medical research through recognition of research excellence, education and advocacy.  As an infectious disease physician, she is passionate about caring for the underserved, strengthening public health infrastructure and addressing the social determinants of health.  She is committed to advancing inclusion in science, including advocating for gender and racial/ethnic equity in academic medicine.

Dr. Pomeroy was inducted into the National Academy of Medicine in 2011.  She has received honorary degrees from the University of Massachusetts Medical School (2016) and the University of South Florida Morsani School of Medicine (2022).

She currently serves on the Board of the Morehouse School of Medicine; Science Philanthropy Alliance; Science Communication Lab; Explore Biology; and the Center for Women in Academic Medicine and Science.  She also serves on the Board of Directors for Sierra Health Foundation; Haemonetics Corporation; and Embecta Corporation, positions for which she receives compensation.

Dr. Pomeroy received her medical degree from the University of Michigan and completed her residency and fellowship at the University of Minnesota. She earned an MBA from the University of Kentucky.  Previous positions include chief of infectious diseases and associate dean for research at the University of Kentucky.  She was vice chancellor and dean of the University of California, Davis School of Medicine from 2005 – 2013.  She became president of the Lasker Foundation in June 2013.

Dr. Pomeroy has a long track record of mentoring diverse leaders in academic medicine, medical research and healthcare, including laboratory trainees, graduate students, post-doctoral scholars and junior and mid-career faculty.  She is a sought-after advisor to senior leaders, including current mentoring through the CWAMS Faculty Advisory Network and the Carol Emmott Fellowship program.

 Back to Board of Directors and Officers